Race Oncology Initiates First Australian Site for Advanced Solid Tumor Study

MT NewswiresMar 27 23:51 ET

Daniel Tillett on Race Oncology's Drug Advancements | ASX:RAC, OTC:RAONF

Proactive InvestorsMar 20 20:09 ET

Race Oncology Approved for Phase I Trial for Chemotherapeutic Treatments

The Market HeraldMar 13 19:10 ET

Race Oncology's (ASX:RAC) Investors Will Be Pleased With Their Stellar 240% Return Over the Last Five Years

Yahoo FinanceMar 9 18:03 ET

Race Oncology Signs Nearly AU$9 Million Contract to Support Drug Candidate Development

MT NewswiresMar 5 00:35 ET

Race Oncology Ltd: Appendix 4D & Half-Year Financial Statements

ASXFeb 24 21:42 ET · Announcements